Hospital
Providence Health & Services Washington
Providence Health & Services Washington was paid $11.39M by Medicaid between Jan 2018 and Dec 2024, across 59 billing codes. Its largest line is 99285, emergency room visit (most serious) — 23% of everything it billed.
33Billing provider infoPROVIDENCE HEALTH & SERVICES WASHINGTON
KODIAK, AK 99615
KODIAK, AK 99615
33aNPI1013905660assigned 10/07/2005
33bProvider typeCritical Access Hospital
28Total paid$11.39M
24GClaims60,693
24DCodes billed59
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Alaska
Rank by total paid#6 of 8
Median peer was paid$17.70M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,742 | $1.28M | |
| 2019 | 10,194 | $1.51M | |
| 2020 | 7,618 | $1.20M | |
| 2021 | 8,444 | $1.41M | |
| 2022 | 8,065 | $1.71M | |
| 2023 | 8,408 | $2.06M | |
| 2024incomplete | 8,222 | $2.22M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 23% | 2,063 | 1,612 | $2.64M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 3,151 | 2,423 | $2.40M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 3,138 | 2,642 | $1.51M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 13% | 7,780 | 2,554 | $1.50M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 4.9% | 3,167 | 1,071 | $553K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4.2% | 1,851 | 1,619 | $484K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.6% | 4,665 | 1,410 | $411K |
| 71046 | Radiologic examination, chest; 2 views | 2.9% | 1,336 | 1,244 | $331K |
| 80053 | Comprehensive metabolic panel | 2.2% | 5,260 | 4,044 | $251K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.4% | 942 | 799 | $160K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.4% | 5,797 | 4,454 | $158K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 688 | 499 | $132K |
47 more codes
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,505 | $104K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,251 | $97K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 509 | $73K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 538 | $69K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 640 | $66K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 57 | $54K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 349 | $38K |
| 81001 | <1% | 2,092 | $38K | |
| J3490 | Unclassified drugs | <1% | 720 | $29K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 1,922 | $28K |
| 84484 | <1% | 1,110 | $28K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 580 | $25K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 29 | $19K |
| 86140 | <1% | 920 | $17K | |
| 83735 | <1% | 604 | $14K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 247 | $13K |
| 82077 | <1% | 519 | $12K | |
| 71045 | Radiologic examination, chest; single view | <1% | 63 | $12K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 585 | $12K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 174 | $10K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 42 | $10K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 155 | $9K |
| 80306 | <1% | 358 | $8K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 320 | $8K |
| 83690 | <1% | 454 | $7K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 570 | $7K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 332 | $7K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 178 | $7K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 75 | $6K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 283 | $5K |
| A9150 | Non-prescription drugs | <1% | 1,009 | $5K |
| 97162 | <1% | 16 | $2K | |
| 81025 | <1% | 83 | $2K | |
| J2704 | Injection, propofol, 10 mg | <1% | 99 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 17 | $2K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 114 | $1K |
| 96376 | <1% | 15 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,098 | $962.85 |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 14 | $808.82 |
| 82962 | <1% | 35 | $730.01 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 30 | $345.24 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 45 | $333.42 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 12 | $236.99 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 26 | $140.24 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 15 | $106.74 |
| 85610 | <1% | 29 | $84.19 | |
| 83605 | <1% | 17 | $80.41 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANDERSON, DONALD (ASSISTANT SECRETARY OF ENROLLMENTS)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.